To assess the prognostic impact of ACKR3 platelet surface expression, we performed regression analysis to determine the impact of the expression levels of ACKR3 in a consecutive cohort of patients with symptomatic CAD (n = 389) (Supplementary Tables 4 and 5). The gene discussed is ACKR3; the disease is coronary artery disorder.